References
- Lin S, Schranz J, Teutsch S. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358–366.
- Metcalf SC, Dockrell DH. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocom-promised hosts. J Infect 2007;55:287–299.
- Oakley KL, Moore CB, Denning DW. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp. Antimicrob Agents Chemother 1998;42:2726–2730.
- Tawara S, Ikeda F, Maki K, . In vitro activities of a new lipopep-tide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 2000;44:57–62.
- Morris MI, Vilmann M. Echinocandins in the management of invasive fungal infections, part 1. Am J Health Syst Pharm 2006;63:1693–1703.
- Clinical and Laboratory Standards Institute (formerly NCCLS). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi-approved standard, 2nd. CLSI document M38-A2. CLSI, Wayne, PA, USA, 2008.
- Martin-Mazuelos E, Pemán J, Valverde A, . Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38 – A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 2003;52:365–370.
- Serrano MC, Morilla D, Valverde A, . Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole. J Clin Microbiol 2003;41:5270–5272.
- Espinel-Ingroff A. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp. and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 2006;44:3616–3622.
- Guinea J, Peláez T, Recio S, . In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium and Scedosporium species. Antimicrob Agents Chemother 2008;52:1396–1400.
- Espinel-Ingroff A. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol 2003;41:403–409.
- Arendrup MC, Perkhofer S, Howard SJ, . Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 2008;52:3504–3511.
- Verweij PE, Brandt ME. Aspergillus, Fusarium and other opportunistic moniliaceous fungi. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology, 9th. Washington: ASM Press, 2007: 1802–1838.
- Clinical and Laboratory Standards Institute (formerly NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard, 3rd. CLSI document M27-A3. CLSI, Wayne, PA, USA, 2008.
- Maida CM, Milici ME, Trovato L, . Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi. J Clin Microbiol 2008;46:4071–4074.
- Arikan S, Yurdakul P, Hascelik G. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother 2003;47:2640–2643.